Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 22 | 2024 | 415 | 4.230 |
Why?
|
| Electronic Nicotine Delivery Systems | 11 | 2024 | 215 | 3.950 |
Why?
|
| Tobacco, Smokeless | 11 | 2021 | 43 | 3.880 |
Why?
|
| Tobacco Use Disorder | 15 | 2021 | 117 | 3.860 |
Why?
|
| Tobacco Products | 8 | 2026 | 205 | 3.000 |
Why?
|
| Hotlines | 12 | 2024 | 29 | 2.670 |
Why?
|
| Smoking | 18 | 2024 | 477 | 2.350 |
Why?
|
| Vaping | 4 | 2024 | 139 | 2.230 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2019 | 63 | 2.220 |
Why?
|
| Oklahoma | 38 | 2024 | 1052 | 2.180 |
Why?
|
| Indians, North American | 11 | 2018 | 544 | 2.050 |
Why?
|
| Commerce | 5 | 2026 | 60 | 2.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2019 | 303 | 1.850 |
Why?
|
| Cigarette Smoking | 3 | 2018 | 82 | 1.510 |
Why?
|
| Smoking Prevention | 10 | 2015 | 90 | 1.480 |
Why?
|
| Tobacco Use Cessation | 6 | 2016 | 31 | 1.450 |
Why?
|
| Adult | 46 | 2024 | 8024 | 1.380 |
Why?
|
| Humans | 75 | 2026 | 28851 | 1.340 |
Why?
|
| Adolescent | 26 | 2024 | 3193 | 1.290 |
Why?
|
| Tobacco Use | 6 | 2019 | 103 | 1.220 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 360 | 1.220 |
Why?
|
| Male | 46 | 2024 | 13921 | 1.210 |
Why?
|
| Smokers | 4 | 2021 | 128 | 1.190 |
Why?
|
| Female | 49 | 2024 | 15624 | 1.130 |
Why?
|
| Young Adult | 24 | 2021 | 2833 | 1.130 |
Why?
|
| Middle Aged | 33 | 2024 | 7414 | 1.090 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2019 | 37 | 1.060 |
Why?
|
| Psychometrics | 5 | 2021 | 122 | 0.920 |
Why?
|
| Urban Population | 1 | 2026 | 95 | 0.910 |
Why?
|
| Aged | 22 | 2021 | 5598 | 0.880 |
Why?
|
| Rural Population | 1 | 2026 | 131 | 0.880 |
Why?
|
| Health Promotion | 2 | 2015 | 179 | 0.830 |
Why?
|
| Tobacco Industry | 2 | 2015 | 33 | 0.780 |
Why?
|
| Nicotine | 2 | 2024 | 86 | 0.750 |
Why?
|
| Health Education | 3 | 2015 | 75 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 344 | 0.660 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 137 | 0.630 |
Why?
|
| Cotinine | 7 | 2021 | 46 | 0.590 |
Why?
|
| Referral and Consultation | 3 | 2016 | 98 | 0.580 |
Why?
|
| Carcinogens | 1 | 2018 | 39 | 0.580 |
Why?
|
| Tobacco | 4 | 2022 | 87 | 0.550 |
Why?
|
| Surveys and Questionnaires | 11 | 2021 | 997 | 0.540 |
Why?
|
| Taxes | 2 | 2015 | 12 | 0.540 |
Why?
|
| Logistic Models | 8 | 2019 | 410 | 0.530 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 787 | 0.530 |
Why?
|
| Patient Selection | 1 | 2018 | 150 | 0.520 |
Why?
|
| Licensure | 1 | 2016 | 4 | 0.500 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2015 | 2 | 0.480 |
Why?
|
| Survivors | 1 | 2016 | 40 | 0.470 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 15 | 0.460 |
Why?
|
| Mortality | 1 | 2015 | 46 | 0.450 |
Why?
|
| United States | 9 | 2018 | 2222 | 0.450 |
Why?
|
| Mouth Neoplasms | 1 | 2015 | 64 | 0.440 |
Why?
|
| Socioeconomic Factors | 5 | 2019 | 260 | 0.430 |
Why?
|
| Labor, Induced | 2 | 2007 | 19 | 0.420 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 105 | 0.410 |
Why?
|
| Pregnancy Outcome | 3 | 2007 | 131 | 0.410 |
Why?
|
| Saliva | 5 | 2019 | 96 | 0.400 |
Why?
|
| Sex Factors | 5 | 2019 | 467 | 0.380 |
Why?
|
| Quality of Life | 1 | 2016 | 521 | 0.360 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 100 | 0.350 |
Why?
|
| Prevalence | 7 | 2015 | 518 | 0.330 |
Why?
|
| Adolescent Behavior | 3 | 2011 | 68 | 0.330 |
Why?
|
| Health Behavior | 4 | 2016 | 159 | 0.320 |
Why?
|
| Age Factors | 5 | 2019 | 737 | 0.320 |
Why?
|
| Apgar Score | 2 | 2007 | 2 | 0.290 |
Why?
|
| Obesity | 1 | 2015 | 699 | 0.290 |
Why?
|
| Placenta Diseases | 2 | 2000 | 4 | 0.290 |
Why?
|
| Self Report | 2 | 2019 | 121 | 0.280 |
Why?
|
| Schools | 2 | 2026 | 90 | 0.270 |
Why?
|
| Risk-Taking | 1 | 2008 | 61 | 0.270 |
Why?
|
| Placenta | 2 | 2000 | 78 | 0.270 |
Why?
|
| Program Evaluation | 4 | 2020 | 174 | 0.270 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2007 | 1 | 0.260 |
Why?
|
| Obstetric Labor Complications | 1 | 2007 | 18 | 0.260 |
Why?
|
| Data Collection | 4 | 2015 | 106 | 0.260 |
Why?
|
| Public Health | 2 | 2015 | 95 | 0.260 |
Why?
|
| Alcoholism | 1 | 2008 | 121 | 0.260 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 3 | 2012 | 94 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 995 | 0.250 |
Why?
|
| Neoplasms | 1 | 2016 | 874 | 0.250 |
Why?
|
| Laos | 1 | 2026 | 15 | 0.250 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 1032 | 0.240 |
Why?
|
| Incidence | 3 | 2015 | 572 | 0.220 |
Why?
|
| Cesarean Section | 2 | 2007 | 55 | 0.220 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 429 | 0.210 |
Why?
|
| Health Policy | 2 | 2015 | 61 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 74 | 0.200 |
Why?
|
| Research Design | 2 | 2018 | 187 | 0.200 |
Why?
|
| Smartphone | 1 | 2024 | 75 | 0.200 |
Why?
|
| Retrospective Studies | 4 | 2022 | 2635 | 0.200 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 2065 | 0.190 |
Why?
|
| Risk Factors | 6 | 2012 | 2126 | 0.190 |
Why?
|
| School Health Services | 1 | 2002 | 36 | 0.180 |
Why?
|
| Life Style | 1 | 2002 | 91 | 0.180 |
Why?
|
| Students | 2 | 2002 | 199 | 0.180 |
Why?
|
| District of Columbia | 1 | 2021 | 10 | 0.170 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 21 | 0.170 |
Why?
|
| Child | 7 | 2015 | 2287 | 0.170 |
Why?
|
| Epidemiology | 1 | 2000 | 1 | 0.170 |
Why?
|
| Education, Continuing | 1 | 2000 | 11 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2000 | 8 | 0.170 |
Why?
|
| Pregnancy | 7 | 2010 | 1254 | 0.170 |
Why?
|
| Biometry | 1 | 2000 | 20 | 0.160 |
Why?
|
| Psychological Tests | 1 | 2000 | 21 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2000 | 26 | 0.160 |
Why?
|
| Perception | 1 | 2021 | 90 | 0.160 |
Why?
|
| Intention | 1 | 2021 | 79 | 0.160 |
Why?
|
| Program Development | 1 | 2000 | 87 | 0.160 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Electronic Mail | 1 | 2019 | 10 | 0.160 |
Why?
|
| Self Concept | 1 | 2000 | 53 | 0.160 |
Why?
|
| Mass Screening | 1 | 2021 | 158 | 0.160 |
Why?
|
| Text Messaging | 1 | 2019 | 22 | 0.160 |
Why?
|
| Public Policy | 1 | 2019 | 21 | 0.150 |
Why?
|
| Interviews as Topic | 1 | 2019 | 162 | 0.140 |
Why?
|
| State Government | 2 | 2015 | 18 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 481 | 0.140 |
Why?
|
| Social Norms | 2 | 2015 | 12 | 0.140 |
Why?
|
| Odds Ratio | 3 | 2008 | 237 | 0.140 |
Why?
|
| Depression | 1 | 2000 | 225 | 0.140 |
Why?
|
| Student Dropouts | 1 | 2018 | 3 | 0.140 |
Why?
|
| Social Class | 1 | 2018 | 81 | 0.130 |
Why?
|
| Confidence Intervals | 2 | 2008 | 69 | 0.130 |
Why?
|
| Medical Records | 2 | 2012 | 51 | 0.130 |
Why?
|
| Biomarkers | 2 | 2018 | 776 | 0.130 |
Why?
|
| Time Factors | 3 | 2015 | 1613 | 0.130 |
Why?
|
| Population Surveillance | 3 | 2012 | 86 | 0.120 |
Why?
|
| Pregnancy, High-Risk | 1 | 1996 | 6 | 0.120 |
Why?
|
| Body Weight | 2 | 2015 | 250 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 463 | 0.120 |
Why?
|
| Infant, Newborn | 5 | 2010 | 916 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2017 | 2426 | 0.120 |
Why?
|
| International Classification of Diseases | 2 | 2012 | 38 | 0.120 |
Why?
|
| Hospitals | 1 | 2015 | 77 | 0.120 |
Why?
|
| SEER Program | 1 | 2015 | 47 | 0.110 |
Why?
|
| Economic Competition | 1 | 2015 | 7 | 0.110 |
Why?
|
| Community Networks | 1 | 2015 | 10 | 0.110 |
Why?
|
| Marketing | 1 | 2015 | 35 | 0.110 |
Why?
|
| Smoke-Free Policy | 1 | 2015 | 17 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 78 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 432 | 0.110 |
Why?
|
| Overweight | 1 | 2015 | 114 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 146 | 0.100 |
Why?
|
| Income | 2 | 2011 | 38 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 412 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 811 | 0.100 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 10 | 0.090 |
Why?
|
| Weight Gain | 1 | 2012 | 76 | 0.090 |
Why?
|
| Physical Fitness | 2 | 2002 | 62 | 0.090 |
Why?
|
| Models, Econometric | 1 | 2011 | 5 | 0.090 |
Why?
|
| Pakistan | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cultural Characteristics | 1 | 2011 | 27 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 49 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2011 | 73 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2012 | 245 | 0.080 |
Why?
|
| Infant | 3 | 2012 | 1025 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2011 | 91 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 176 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 176 | 0.080 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 1990 | 11 | 0.080 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2010 | 12 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 302 | 0.080 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1990 | 35 | 0.080 |
Why?
|
| Hematology | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2010 | 897 | 0.070 |
Why?
|
| Physicians | 1 | 2009 | 83 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 136 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 113 | 0.070 |
Why?
|
| Organizational Case Studies | 1 | 2007 | 10 | 0.070 |
Why?
|
| Health Plan Implementation | 1 | 2007 | 9 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2009 | 161 | 0.070 |
Why?
|
| Intensive Care, Neonatal | 1 | 2007 | 17 | 0.060 |
Why?
|
| Lung | 1 | 1990 | 382 | 0.060 |
Why?
|
| Parity | 1 | 2007 | 50 | 0.060 |
Why?
|
| Resuscitation | 1 | 2007 | 59 | 0.060 |
Why?
|
| Liver | 1 | 1990 | 471 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 377 | 0.060 |
Why?
|
| Counseling | 3 | 2012 | 57 | 0.060 |
Why?
|
| Hirsutism | 1 | 2005 | 18 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 190 | 0.060 |
Why?
|
| Hair | 1 | 2005 | 15 | 0.060 |
Why?
|
| Home Care Services | 1 | 2005 | 39 | 0.060 |
Why?
|
| Prenatal Care | 1 | 2005 | 42 | 0.060 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2005 | 65 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 100 | 0.050 |
Why?
|
| Mobile Applications | 1 | 2024 | 80 | 0.050 |
Why?
|
| Health Surveys | 2 | 2018 | 85 | 0.050 |
Why?
|
| Focus Groups | 1 | 2002 | 102 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2012 | 76 | 0.050 |
Why?
|
| Negativism | 1 | 2000 | 2 | 0.040 |
Why?
|
| Kentucky | 1 | 2000 | 6 | 0.040 |
Why?
|
| Peer Review, Health Care | 1 | 2000 | 3 | 0.040 |
Why?
|
| Observer Variation | 1 | 2000 | 46 | 0.040 |
Why?
|
| Attitude to Health | 2 | 2015 | 89 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2000 | 46 | 0.040 |
Why?
|
| Minnesota | 1 | 2020 | 42 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 55 | 0.040 |
Why?
|
| Universities | 1 | 2000 | 124 | 0.040 |
Why?
|
| Bangladesh | 1 | 2019 | 15 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 216 | 0.040 |
Why?
|
| Social Behavior | 1 | 2018 | 54 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2012 | 1173 | 0.030 |
Why?
|
| Help-Seeking Behavior | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 65 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 1996 | 4 | 0.030 |
Why?
|
| Social Control, Informal | 1 | 2015 | 4 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 1996 | 37 | 0.030 |
Why?
|
| Gestational Age | 1 | 1996 | 147 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2017 | 203 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 31 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 233 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1996 | 44 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2015 | 5 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 46 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 201 | 0.030 |
Why?
|
| Telephone | 1 | 2012 | 26 | 0.020 |
Why?
|
| Outpatients | 1 | 2012 | 44 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 155 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 115 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 60 | 0.020 |
Why?
|
| Sexual Abstinence | 1 | 2011 | 6 | 0.020 |
Why?
|
| Coitus | 1 | 2011 | 14 | 0.020 |
Why?
|
| Demography | 1 | 2011 | 93 | 0.020 |
Why?
|
| Bupropion | 1 | 2011 | 2 | 0.020 |
Why?
|
| Nicotinic Agonists | 1 | 2011 | 3 | 0.020 |
Why?
|
| Varenicline | 1 | 2011 | 4 | 0.020 |
Why?
|
| Kansas | 1 | 2011 | 8 | 0.020 |
Why?
|
| Self-Help Groups | 1 | 2011 | 15 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2011 | 17 | 0.020 |
Why?
|
| Benzazepines | 1 | 2011 | 12 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 485 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 310 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 91 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 325 | 0.020 |
Why?
|
| Kuwait | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 1990 | 1 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 1990 | 3 | 0.020 |
Why?
|
| Microsomes | 1 | 1990 | 7 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1990 | 28 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 99 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1990 | 46 | 0.020 |
Why?
|
| Organ Size | 1 | 1990 | 88 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1990 | 57 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 555 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 676 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 612 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1990 | 515 | 0.020 |
Why?
|
| California | 1 | 2007 | 70 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1280 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2005 | 18 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2005 | 15 | 0.010 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 23 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 24 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 15 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 73 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2005 | 19 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 39 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 211 | 0.010 |
Why?
|
| Premature Birth | 1 | 2005 | 58 | 0.010 |
Why?
|
| Family Practice | 1 | 2005 | 45 | 0.010 |
Why?
|
| Educational Status | 1 | 2005 | 112 | 0.010 |
Why?
|
| Gynecology | 1 | 2005 | 60 | 0.010 |
Why?
|
| Obstetrics | 1 | 2005 | 51 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2001 | 43 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 145 | 0.010 |
Why?
|
| Mice | 1 | 1990 | 4802 | 0.010 |
Why?
|
| Animals | 1 | 1990 | 10684 | 0.010 |
Why?
|